Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Research analysts at Seaport Res Ptn issued their Q1 2026 EPS estimates for shares of Jushi in a research report issued on Thursday, March 20th. Seaport Res Ptn analyst S. Randhawa expects that the company will earn ($0.04) per share for the quarter. The consensus estimate for Jushi's current full-year earnings is ($0.23) per share. Seaport Res Ptn also issued estimates for Jushi's Q2 2026 earnings at ($0.04) EPS, Q3 2026 earnings at ($0.04) EPS and Q4 2026 earnings at ($0.04) EPS.
Jushi (OTCMKTS:JUSHF - Get Free Report) last posted its quarterly earnings data on Wednesday, March 12th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.02). The company had revenue of $65.86 million for the quarter, compared to analysts' expectations of $64.03 million.
Separately, Atb Cap Markets lowered Jushi from a "hold" rating to a "strong sell" rating in a research report on Monday, December 9th.
Check Out Our Latest Stock Report on JUSHF
Jushi Stock Performance
JUSHF stock traded up $0.02 during trading on Monday, reaching $0.29. The company had a trading volume of 145,847 shares, compared to its average volume of 268,978. The company has a market cap of $56.14 million, a price-to-earnings ratio of -1.06 and a beta of -0.83. Jushi has a twelve month low of $0.22 and a twelve month high of $0.92. The firm has a 50-day simple moving average of $0.32 and a 200-day simple moving average of $0.38.
About Jushi
(
Get Free Report)
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
Further Reading
Before you consider Jushi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.
While Jushi currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
